Markets:

Overview

News

Currencies

International

Treasuries

State Street SPDR S&P Biotech ETF (NY:XBI)

127.63 -0.41 (-0.32%)

Streaming Delayed Price Updated: 3:07 PM EST, Jan 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about State Street SPDR S&P Biotech ETF

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Stocks Drop On October 7, And Are Poised To Move Lower ↗

October 07, 2024

The S&P 500 fell 90 bps today, closing at 5695, bringing the zero gamma level back into focus. This area has strong support, primarily because it separates the post-FOMC gap higher from the current...

Via Talk Markets

Topics Stocks

Biotech Stocks Poised For Another Big Move In Q4 ↗

October 07, 2024

The healthcare sector can be a safe haven if volatility increases.

Via Talk Markets

Biotech Stocks : Are You A Trader Or A Longer Term Investor? ↗

October 01, 2024

Biotech bull market is intact as indicated by large cap biopharma and the best performing funds.

Via Talk Markets

BCYC: A Promising Play In The Biotech Sector ↗

October 01, 2024

The long-awaited and overdue half-point cut in the federal funds rate was the impetus for the SPDR Biotech ETF to finally break above the 102-103 level. Meanwhile, Bicycle Therapeutics Plc. had a...

Via Talk Markets

Topics ETFs

A Biotech Breakout Will Be Led By Small Caps ↗

September 23, 2024

It’s hard to focus on biotech stocks right now because there are many distractions. The Fed and the rate cuts, AI and semiconductor stocks and geopolitical turmoil seemingly worse than ever.

Via Talk Markets

Topics Artificial Intelligence Economy

Bearish Shooting Star Shines ↗

July 13, 2024

Following signs of resistance in biotech ETF XBI on Friday, a shooting star forms. A bearish retracement may take hold soon..

Via Talk Markets

Topics ETFs

Biotech Boom Ahead? Key Stocks and ETFs to Watch Now

September 23, 2024

The Federal Reserve's recent 50bps rate cut could significantly boost biotech companies by lowering borrowing costs and improving access to capital.

Via MarketBeat

Topics ETFs Economy

The Momentum Is Building, The Markets Are Strong - Just Don’t Chase After Extended Winners ↗

September 22, 2024

Dozens of Top Ranked Magnet stocks breaking out

Via Talk Markets

The Door Is Open, Time For The Fed To Act ↗

September 15, 2024

With the CPI trending down and heading in the right direction, most economists are optimistic that the door is open for the Fed to lower rates. Economists, analysts, and investors are all waiting for...

Via Talk Markets

Topics Economy

Stocks Hit Pause As Economic Uncertainty Tempers The Rally ↗

August 20, 2024

Stocks have been on a red-hot rally, but they’ve hit the brakes right at technical resistance, just as the charts predicted.

Via Talk Markets

Biotech Life Science Trades: Small Caps Are Lagging But Poised For A Q4 Rally ↗

August 13, 2024

Weaker than expected PPI up only 0.1% ignite rally with decline in services. Rate cuts imminent for September.

Via Talk Markets

Healthcare Stocks Are Coming On Strong In July Led By Biotech ↗

July 29, 2024

The biotech rally gained momentum in July with rotation out of technology stocks.

Via Talk Markets

Life May Soon Get Easier for (Some) Biotech Stocks. Here's Why. ↗

July 29, 2024

The Federal Reserve's fight against inflation may soon yield financial benefits.

Via The Motley Fool

Topics Economy

The Dow, The Russell, And The Biotech Sector Are Storming Higher ↗

July 16, 2024

The Dow Jones Industrials have come up 4.2% over the latest five-day, while the Russell 2000 index of U.S. small-caps is up nearly 11% - it’s having its best week in 24 years.

Via Talk Markets

Topics Stocks

AskSlim Market Week - Friday, July 12 ↗

July 12, 2024

An analysis and commentary on the financial markets.

Via Talk Markets

Stocks Are Breaking Down Beneath The Surface ↗

July 09, 2024

Stocks and sectors are showing real signs of weakness despite the headline indexes going higher.

Via Talk Markets

Healthcare Stocks Continue To Lag The Market-Can Anything Help ? ↗

July 08, 2024

Healthcare stocks continue to lag the market up about 6% YTD, helped by Large Cap Biopharma but hurt by United Health.

Via Talk Markets

Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows ↗

July 01, 2024

June saw gains in the U.S. stock market, with tech and biotech leading the way. Semiconductor ETFs saw strong inflows, while utilities lagged.

Via Benzinga

Topics ETFs

5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More ↗

June 24, 2024

Biotech investing is risk-fraught but the returns could be staggering if one chooses to take the educated approach.

Via Benzinga

Soft Inflation Data Boosts Small Caps, Real Estate, Regional Banks; Traders Anticipate Fed Rate Cuts As Stocks React ↗

June 12, 2024

U.S. inflation slowed in May, boosting rate cut prospects. Markets rally ahead of FOMC meeting and assign 70% chance of rate cut in September.

Via Benzinga

Topics Economy

Healthcare And Biotech Investing: Breakthroughs In The Treatment Of Cancer At ASCO ↗

June 10, 2024

Healthcare stocks underperformed YTD because of weakness in UNH and strength in Technology and Communication Services.

Via Talk Markets

June’s Biotech Boom: 3 Stocks to Buy for a Summertime Surge ↗

June 05, 2024

Biotech surge alert! Discover three biotech stocks to buy as they catch up with the market in the rest of 2024.

Via InvestorPlace

American Express, Trade Desk And More: CNBC's 'Final Trades' ↗

June 04, 2024

American Express Company has "above market growth for below market multiple," Amy Raskin of Chevy Chase Trust said.

Via Benzinga

The 3 Most Undervalued Biotech Stocks to Buy in June 2024 ↗

June 04, 2024

https://seekingalpha.com/news/4111624-goldman-sachs-raises-obesity-drug-market-estimate

Via InvestorPlace

Should I Be Worried? Stock Market (And Sentiment Results)… ↗

May 30, 2024

We are aggressively putting money to work in individual companies that are excessively undervalued relative to what we believe their normalized earnings power will look like as their recoveries...

Via Talk Markets

If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names ↗

May 29, 2024

Between FDA approvals and product pipelines, it takes diligence to keep up with which biotech stocks to buy.

Via InvestorPlace

Why the Rest of 2024 Could Be Good for Investing in Biotech Stocks ↗

May 24, 2024

Investors have been ignoring biotech stocks for far too long. Here's why they could start to heat up in 2024.

Via InvestorPlace

For Biotech Stocks To Move Higher, This Must Move Lower ↗

May 15, 2024

While biotechs have significantly lagged behind the broader market, there is reason to be optimistic once inflation-related volatility subsides. IBB and XBI present good vehicles for biotech exposure.

Via Talk Markets

Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential' ↗

May 09, 2024

Elon Musk has come off as a flagbearer of the mRNA technology, which is seen holding out a lot of promise by scientists.

Via Benzinga

AskSlim Market Week - Friday, April 26 ↗

April 26, 2024

An analysis and commentary on the financial markets.

Via Talk Markets

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.